228 related articles for article (PubMed ID: 34223660)
1. A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans.
Arout CA; Haney M; Herrmann ES; Bedi G; Cooper ZD
Br J Clin Pharmacol; 2022 Jan; 88(1):347-355. PubMed ID: 34223660
[TBL] [Abstract][Full Text] [Related]
2. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
Cooper ZD; Bedi G; Ramesh D; Balter R; Comer SD; Haney M
Neuropsychopharmacology; 2018 Sep; 43(10):2046-2055. PubMed ID: 29463913
[TBL] [Abstract][Full Text] [Related]
3. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.
Babalonis S; Haney M; Malcolm RJ; Lofwall MR; Votaw VR; Sparenborg S; Walsh SL
Drug Alcohol Depend; 2017 Mar; 172():9-13. PubMed ID: 28088032
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol - an effective analgesic for toothache?
Murphy S; Hayes E
Evid Based Dent; 2024 Jun; 25(2):100-101. PubMed ID: 38649735
[TBL] [Abstract][Full Text] [Related]
5. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.
Babalonis S; Lofwall MR; Nuzzo PA; Walsh SL
Addict Biol; 2016 Jan; 21(1):146-58. PubMed ID: 25130052
[TBL] [Abstract][Full Text] [Related]
7. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers.
Cooper ZD; Johnson KW; Vosburg SK; Sullivan MA; Manubay J; Martinez D; Jones JD; Saccone PA; Comer SD
Drug Alcohol Depend; 2017 Sep; 178():340-347. PubMed ID: 28688296
[TBL] [Abstract][Full Text] [Related]
8. Sex-dependent effects of cannabis-induced analgesia.
Cooper ZD; Haney M
Drug Alcohol Depend; 2016 Oct; 167():112-20. PubMed ID: 27522535
[TBL] [Abstract][Full Text] [Related]
9. Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.
Huhn AS; Strain EC; Bigelow GE; Smith MT; Edwards RR; Tompkins DA
Anesthesiology; 2019 Jan; 130(1):131-141. PubMed ID: 30418214
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans.
Bergmans RS; Wegryn-Jones R; Klida C; Kurtz V; Thomas L; Williams DA; Clauw DJ; Kidwell KM; Bohnert ASB; Boehnke KF
BMC Complement Med Ther; 2024 Jun; 24(1):250. PubMed ID: 38951902
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol as an Alternative Analgesic for Acute Dental Pain.
Chrepa V; Villasenor S; Mauney A; Kotsakis G; Macpherson L
J Dent Res; 2024 Mar; 103(3):235-242. PubMed ID: 37910667
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
Cooper ZD; Comer SD; Haney M
Neuropsychopharmacology; 2013 Sep; 38(10):1984-92. PubMed ID: 23609132
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Langford RM; Mares J; Novotna A; Vachova M; Novakova I; Notcutt W; Ratcliffe S
J Neurol; 2013 Apr; 260(4):984-97. PubMed ID: 23180178
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers.
Cooper ZD; Sullivan MA; Vosburg SK; Manubay JM; Haney M; Foltin RW; Evans SM; Kowalczyk WJ; Saccone PA; Comer SD
Behav Pharmacol; 2012 Jun; 23(3):271-9. PubMed ID: 22495183
[TBL] [Abstract][Full Text] [Related]
15. Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I).
Schneider T; Zurbriggen L; Dieterle M; Mauermann E; Frei P; Mercer-Chalmers-Bender K; Ruppen W
Pain; 2022 Jan; 163(1):e62-e71. PubMed ID: 34086631
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans.
Babalonis S; Lofwall MR; Sloan PA; Nuzzo PA; Fanucchi LC; Walsh SL
Psychopharmacology (Berl); 2019 Nov; 236(11):3341-3352. PubMed ID: 31201479
[TBL] [Abstract][Full Text] [Related]
17. The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: A balanced placebo design trial.
De Vita MJ; Maisto SA; Gilmour CE; McGuire L; Tarvin E; Moskal D
Exp Clin Psychopharmacol; 2022 Oct; 30(5):536-546. PubMed ID: 34251840
[TBL] [Abstract][Full Text] [Related]
18. Tilidine and dipyrone (metamizole) in cold pressor pain: A pooled analysis of efficacy, tolerability, and safety in healthy volunteers.
Kleine-Borgmann J; Wilhelmi J; Kratel J; Baumann F; Schmidt K; Zunhammer M; Bingel U
Clin Transl Sci; 2021 Sep; 14(5):1997-2007. PubMed ID: 34058081
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
20. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
